Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Pancarcinoma T/Tn antigen detects human carcinoma long before biopsy does and its vaccine prevents breast carcinoma recurrence.

Springer GF, Desai PR, Tegtmeyer H, Spencer BD, Scanlon EF.

Ann N Y Acad Sci. 1993 Aug 12;690:355-7. No abstract available.

PMID:
8368754
3.

T/Tn pancarcinoma autoantigens: fundamental, diagnostic, and prognostic aspects.

Springer GF, Desai PR, Ghazizadeh M, Tegtmeyer H.

Cancer Detect Prev. 1995;19(2):173-82.

PMID:
7750105
4.

Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.

Springer GF.

J Mol Med (Berl). 1997 Aug;75(8):594-602. Review.

PMID:
9297627
5.

A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.

Lo-Man R, Vichier-Guerre S, Perraut R, Dériaud E, Huteau V, BenMohamed L, Diop OM, Livingston PO, Bay S, Leclerc C.

Cancer Res. 2004 Jul 15;64(14):4987-94.

7.
8.

Vaccination with Theratope (STn-KLH) as treatment for breast cancer.

Holmberg LA, Sandmaier BM.

Expert Rev Vaccines. 2004 Dec;3(6):655-63. Review.

PMID:
15606349
9.

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.

MacLean GD, Reddish M, Koganty RR, Wong T, Gandhi S, Smolenski M, Samuel J, Nabholtz JM, Longenecker BM.

Cancer Immunol Immunother. 1993;36(4):215-22.

PMID:
8439984
10.

Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.

Lo-Man R, Vichier-Guerre S, Bay S, Dériaud E, Cantacuzène D, Leclerc C.

J Immunol. 2001 Feb 15;166(4):2849-54.

11.

Tn, a universal carcinoma (CA) marker, frequently strongly expressed in anaplastic, aggressive CA.

Springer GF, Tegtmeyer H.

Naturwissenschaften. 1983 Dec;70(12):621-2. No abstract available.

PMID:
6674816
12.
13.
14.

Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.

O'Boyle KP, Markowitz AL, Khorshidi M, Lalezari P, Longenecker BM, Lloyd KO, Welt S, Wright KE.

Hybridoma. 1996 Dec;15(6):401-8.

PMID:
8985750
15.

Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.

Imai J, Ghazizadeh M, Naito Z, Asano G.

Anticancer Res. 2001 Mar-Apr;21(2B):1327-34.

PMID:
11396208
16.
17.

The use of carbohydrate antigens for the preparation of vaccines for therapy in breast cancer.

Croce MV, Segal-Eiras A.

Drugs Today (Barc). 2002 Nov;38(11):759-68. Review.

PMID:
12582459
18.

Value of radiography of the remaining breast following mastectomy for carcinoma.

Kolbenstvedt A, Heldaas O.

Acta Radiol Diagn (Stockh). 1973 Jul;14(4):435-41. No abstract available.

PMID:
4748172
19.

T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma.

Springer GF, Desai PR, Tegtmeyer H, Carlstedt SC, Scanlon EF.

Cancer Biother. 1994 Spring;9(1):7-15.

PMID:
7812359
20.

[Breast cancer].

Ataseven B, Eiermann W.

Dtsch Med Wochenschr. 2006 May 12;131(19):1091-9; quiz 1101-2. Review. German. No abstract available.

PMID:
16685631

Supplemental Content

Support Center